+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • August 2025
  • Region: United States
  • GlobalData
  • ID: 4377318
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is a cancer care center. It offers cancer treatment, cancer research, education, and research-based prevention of both common and rare cancers in adult and pediatric patients. The company's major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers graduate, undergraduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

  • Aug 11, 2025: Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025
  • Jul 10, 2025: Most Patients With Advanced Melanoma Who Received Pre-surgical Immunotherapy Remain Alive and Disease Free Four Years Later
  • Jun 10, 2025: Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
  • Jun 09, 2025: MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • University of Texas MD Anderson Cancer Center - Key Facts
  • University of Texas MD Anderson Cancer Center - Key Employees
  • University of Texas MD Anderson Cancer Center - Key Employee Biographies
  • University of Texas MD Anderson Cancer Center - Major Products and Services
  • University of Texas MD Anderson Cancer Center - History
  • University of Texas MD Anderson Cancer Center - Company Statement
  • University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • University of Texas MD Anderson Cancer Center - Business Description
  • Business Segment: Auxiliary Income
  • Performance
  • Business Segment: Grants and Contracts
  • Performance
  • Business Segment: Net Patient Service Revenue
  • Performance
  • Business Segment: Net Professional Fees
  • Performance
  • Business Segment: Net Sales and Services of Educational Activities
  • Performance
  • Business Segment: Other Income
  • Performance
  • R&D Overview
  • University of Texas MD Anderson Cancer Center - Corporate Strategy
  • University of Texas MD Anderson Cancer Center - SWOT Analysis
  • SWOT Analysis - Overview
  • University of Texas MD Anderson Cancer Center - Strengths
  • University of Texas MD Anderson Cancer Center - Weaknesses
  • University of Texas MD Anderson Cancer Center - Opportunities
  • University of Texas MD Anderson Cancer Center - Threats
  • University of Texas MD Anderson Cancer Center - Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 3 - Company’s Recent Developments
  • Aug 11, 2025: Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025
  • Jul 10, 2025: Most Patients With Advanced Melanoma Who Received Pre-surgical Immunotherapy Remain Alive and Disease Free Four Years Later
  • Jun 10, 2025: Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
  • Jun 09, 2025: MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access
  • May 28, 2025: New biomarker may guide best use of KRAS inhibitors in lung cancer
  • May 21, 2025: CPRIT Awards Over $21 Million to MD Anderson for Cancer Research and Faculty Recruitment
  • May 15, 2025: Texas Children''s Hospital and UT MD Anderson Announce $150 Million Gift from Kinder Foundation to Launch Kinder Children''s Cancer Center
  • Apr 30, 2025: Jointly Funded Research Explores Cutting-Edge RNA Sequencing in Rare Ovarian Cancer
  • Mar 18, 2025: Oribiotech Announces Launch of Preferred Partner Network
  • Feb 13, 2025: Scientists Find New Biomarker That Predicts Cancer Aggressiveness
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • University of Texas MD Anderson Cancer Center, Key Facts
  • University of Texas MD Anderson Cancer Center, Key Employees
  • University of Texas MD Anderson Cancer Center, Key Employee Biographies
  • University of Texas MD Anderson Cancer Center, Major Products and Services
  • University of Texas MD Anderson Cancer Center, History
  • University of Texas MD Anderson Cancer Center, Other Locations
  • University of Texas MD Anderson Cancer Center, Subsidiaries
  • University of Texas MD Anderson Cancer Center, Joint Venture
  • University of Texas MD Anderson Cancer Center, Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Baylor St Luke's Medical Center
  • TIRR Memorial Hermann
  • Houston Methodist Hospital
  • Cancer Therapy and Research Center
  • Texas Children's Cancer Center